Siponimod and CYP2C9 Allele Prevalence Among Blacks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Siponimod and CYP2C9 Allele Prevalence Among Blacks

Published:2019-11-07 Issue:4 Volume:60 Page:429-431
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Liu Michelle¹,Obeng Aniwaa Owusu²³⁴

Affiliation:

1. Department of Pharmaceutical ServicesVanderbilt University Medical Center Nashville Tennessee USA

2. The Charles Bronfman Institute for Personalized MedicineIcahn School of Medicine at Mount Sinai New York New York USA

3. Department of Genetics and Genomic SciencesIcahn School of Medicine at Mount Sinai New York New York USA

4. Pharmacy DepartmentThe Mount Sinai Hospital New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1546

Reference15 articles.

1. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

2. Mayzent (siponimod) [package insert].East Hanover NJ:Novartis Pharmaceuticals Corporation;2019.

3. Siponimod for the treatment of secondary progressive multiple sclerosis

4. Multiple sclerosis prevalence in the United States commercially insured population

5. Incidence of multiple sclerosis in multiple racial and ethnic groups

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cas12a-based one-pot SNP detection with high accuracy;Cell Insight;2023-04

2. The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and ( S )‐Warfarin;Clinical Pharmacology & Therapeutics;2022-05-05

3. Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine;2022-04

4. Synthesis of 5-Trifluoromethyl-Substituted (Z)-N,N-Dimethyl-N′-(pyrazin-2-yl)formimidamides from 2-Aminopyrazines, LiI/Selectfluor, FSO2CF2CO2Me and DMF under Cu Catalysis;Synthesis;2022-02-09

5. Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: when will we achieve parity?;CNS Spectrums;2021-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3